Ambrx raises $45M

Ambrx Inc. (San Diego, Calif.) said it raised $45 million in a financing round led by Apricot Capital and Northeast Securities Prosperity Healthcare Fund. Sinopharm Capital, Humanwell Healthcare Fund, Fosun Capital, Hopu Investments and the healthcare fund of China Everbright Ltd. (HKSE:165) also participated.

Everbright, Fosun, Hopu and WuXi PharmaTech Inc. (NYSE:WX) acquired Ambrx last year for an undisclosed amount. Ambrx is developing a pipeline of antibody-drug conjugates (ADCs), bispecific and multi-specific drug conjugates, and long-acting proteins. ...